Healionics
Mr. Connolly has over 30 years of experience in the medical device industry as an entrepreneur, venture capitalist, and CEO. He co-founded several device companies, three of which (Novacept, Cohesion Technologies, Pulmonx) have reached exits worth a combined $2B. He also led the regional office for $400M venture capital firm vSpring (now Signal Peak), and has served as CEO of two early-stage device companies. Mr. Connolly previously served as a Navy officer on a destroyer and taught physics at the U.S. Naval Academy. He has an MBA from Stanford, MS in mechanical engineering from MIT, and BS from the U.S. Naval Academy.
This person is not in any offices
Healionics
Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.